id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-0474-0007,FDA,FDA-2013-E-0474,Notice of Determination from U.S. Patent and Trademark Office to the FDA CDER,Proposed Rule,Notice of Extension,2016-12-20T05:00:00Z,2016,12,2016-12-20T05:00:00Z,,2016-12-20T15:51:09Z,,0,0,090000648242a23d
FDA-2013-E-0474-0006,FDA,FDA-2013-E-0474,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2016-08-01T04:00:00Z,2016,8,2016-08-01T04:00:00Z,,2016-08-02T02:45:26Z,,0,0,090000648214b3e7
FDA-2013-E-0474-0005,FDA,FDA-2013-E-0474,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T02:06:59Z,,0,0,0900006481dd601b
FDA-2013-E-0474-0004,FDA,FDA-2013-E-0474,"Determination of Regulatory Review Period for Purposes of Patent
Extension; XTANDI",Notice,Determinations,2015-12-18T05:00:00Z,2015,12,2015-12-18T05:00:00Z,2016-02-17T04:59:59Z,2015-12-18T14:43:32Z,2015-31824,0,0,0900006481db9890
FDA-2013-E-0474-0003,FDA,FDA-2013-E-0474,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2013-07-23T04:00:00Z,2013,7,2013-07-23T04:00:00Z,,2024-03-15T12:56:42Z,,0,0,0900006481375ce0
FDA-2013-E-0474-0001,FDA,FDA-2013-E-0474,University of California (Venable LLP) - Patent Term Application,Other,Application,2013-04-23T04:00:00Z,2013,4,2013-04-23T04:00:00Z,,2013-04-23T12:26:45Z,,0,0,09000064812a1bfc
FDA-2013-E-0474-0002,FDA,FDA-2013-E-0474,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-04-23T04:00:00Z,2013,4,2013-04-23T04:00:00Z,,2013-04-23T12:26:46Z,,0,0,09000064812a1bfe